Dr Stefan Hellbardt is Vice-President Business Development and Scientific Affairs within Aptar Pharma’s Consumer Health Care division. As a trained biologist, he earned his PhD at the German Cancer Research Center (Heidelberg, Germany). Having held various positions in the pharmaceutical industry, Dr Hellbardt gained more than 12 years’ experience in clinical development before joining Aptar Pharma in 2011 to lead global business development for the dermal drug delivery, wound care and analgesics application fields. In this role, he has been instrumental in delivering Aptar Pharma’s expertise and services to both new and existing customers, as well as developing pharmaceutical products for topical dermal, transdermal, topical analgesic and wound applications. In his Scientific Affairs role, Dr Hellbardt has been leading a team of scientists since 2020, supporting customers with Aptar Pharma’s preservative-free products and material characterisation services.